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TO ANG II IN CYP1A1-REN2 TRANSGENIC RATS
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Abstract
Background—Transgenic rats with inducible expression of the mouse Ren2 renin gene [strain
name: TGR(Cyp1a1Ren2)] allow induction of various degrees of ANG II-dependent hypertension.
Dietary administration of the aryl hydrocarbon indole-3-carbinol (I3C) at a dose of 0.15% induces
a slowly developing form of ANG II-dependent hypertension whereas dietary administration of a
higher dose (0.3%) of I3C results in the development of ANG II-dependent malignant hypertension.
Cessation of administration of 0.15% I3C results in the normalization of blood pressure, indicating
the reversibility of hypertension induced by this dose of I3C. The present study was performed to
determine if ANG II-dependent malignant hypertension is similarly reversible following cessation
of dietary administration of 0.3% I3C.
Methods—Cyp1a1-Ren2 rats (n=6) were fed a normal diet containing 0.3% I3C for 11 days to
induce malignant hypertension.
Results—Cyp1a1-Ren2 rats induced with I3C exhibited pronounced increases in systolic blood
pressure (SBP) (132±3 to 229±11 mmHg, P<0.001) and marked decreases in body weight (303±4
to 222±2 g, P<0.001). When I3C administration was terminated, SBP decreased to 167±4 mmHg
(P<0.01) and body weight increased to normal levels (309±2 g, P<0.01) within 12 days. However,
SBP remained significantly elevated (172±1 mmHg, P<0.01) for up to 3 weeks following termination
of dietary administration of 0.3% I3C. In addition, the magnitude of the blood pressure response to
intravenous bolus administration of 50 ng of ANG II (50 μl in volume) 3 weeks following cessation
of dietary I3C administration was substantially higher than that observed in normotensive control
rats (134±1 mmHg, n=6) not previously induced with 0.3% I3C (53±2 vs. 38±3 mmHg, P<0.05).
Conclusions—The present findings demonstrate that transient induction of ANG II-dependent
malignant hypertension results in prolonged elevations of arterial blood pressure and marked
augmentation of the magnitude of the pressor response to ANG II in Cyp1a1-Ren2 transgenic rats.
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Introduction
The transgenic rat line with inducible expression of the mouse Ren2 renin gene [strain name:
TGR(Cyp1a1Ren2)] was created by inserting the mouse Ren2 renin gene, fused to an 11.5 kb
fragment of the cytochrome P450 1a1 (Cyp1a1) promoter, into the genome of the Fischer 344
rat.1 Cyp1a1, which catalyzes the oxidation of a wide range of endogenous lipophilic
compounds and xenobiotics2–4, is not constitutively expressed, but is highly inducible upon
exposure to various aryl hydrocarbons such as indole-3-carbinol (I3C).2–8 Induction of Cyp1a1
is mediated by the aryl hydrocarbon receptor, which is a basic helix-loop-helix-transcription
factor that binds to specific DNA elements in the Cyp1a1 promoter.2,4,9 Rats transgenic for
the Cyp1a1-Ren2 construct do not constitutively express the Ren2 renin gene. Rather, the
Ren2 gene is expressed primarily in the liver, only upon induction of the Cyp1a1 promoter by
aryl hydrocarbons such as I3C.1 In this transgenic rat line, induction of the Cyp1a1 promoter
by dietary administration of I3C results in a fixed level of expression of the Ren2 renin gene
and in the development of ANG II-dependent hypertension.1,10–17 Dietary administration of
I3C at a dose of 0.15% induces a slowly developing form of ANG II-dependent hypertension
whereas dietary administration of a higher dose (0.3%) of I3C results in the development of
ANG II-dependent malignant hypertension.10–17 Cessation of administration of 0.15% I3C
results in the normalization of blood pressure, indicating the reversibility of hypertension
induced by this dose of I3C.10 The present study was performed to determine if ANG II-
dependent malignant hypertension is similarly reversible following cessation of dietary
administration of 0.3% I3C. In the present study, transient induction of malignant hypertension
induced prolonged elevations of systolic blood pressure (SBP) following cessation of dietary
I3C administration. Accordingly, an additional objective was to determine the ANG II-
dependence of the sustained elevation of arterial blood pressure following cessation of dietary
administration of 0.3% I3C.
Methods
The experimental procedures in this study conform to the National Institutes of Health Guide
for the Care and Use of Laboratory Animals and were approved by the Institutional Animal
Care and Use Committee of Tulane University Health Sciences Center. Experiments were
performed on adult male transgenic rats [TGR(Cyp1a1Ren2)] with inducible expression of the
mouse Ren2 renin gene.1 All transgenic rats used in the present study were bred at Tulane
University School of Medicine from stock animals supplied by Harlan UK Limited, Bicester,
UK. The experimental animals were divided into three groups. Group 1 (Non-induced; n=6)
transgene-negative Fischer 344 rats were maintained on a normal rat diet containing I3C at a
dose of 0.3% (wt/wt; diet TD 05381, Harlan-Teklad, Madison, WI) for 11 days. Group 2 (0.3%
I3C; n=6) Cyp1a1-Ren2 rats were fed a normal diet containing 0.3% I3C for 11 days to induce
ANG II-dependent malignant hypertension. The rats were then placed a normal non-I3C
containing diet (TD 99414, Harlan-Teklad) for 3 weeks. Group 3 (0.3% I3C+Lis; n=6) rats
were fed 0.3% I3C and treated chronically with the angiotensin-converting enzyme (ACE)
inhibitor, lisinopril (Lis; Sigma Chemical, St. Louis, MO) for 11 days. Lisinopril was added
to the drinking water at a concentration of 50 mg/L.
Measurement of systolic blood pressure was obtained in conscious rats using tail-cuff
plethysmography (Model 6R22931, IITC Life Science; Woodland Hills, CA). All rats were
trained for two weeks prior to the beginning of the experiment in order to habituate them to
this procedure. Blood pressures were measured every 1–3 days throughout the duration of the
study. Body weight was measured every day throughout the course of the study. At the
completion of the experimental protocol, renal clearance experiments were performed on all
rats. Rats were anesthetized with pentobarbital sodium (50 mg/kg ip) and placed on a
thermostatically controlled surgical table to maintain body temperature at 37°C. A
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tracheostomy was performed, and the animals were allowed to breathe air enriched with
oxygen, which has been shown to improve the stability of arterial blood pressure of
pentobarbital-anesthetized rats.12,18,19 The left femoral artery was cannulated to allow
continuous monitoring of arterial blood pressure. Blood pressure was monitored with a Statham
pressure transducer (model P23 DC) and recorded using a computerized data acquisition
system (MP100 system; BIOPAC Systems, Santa Barbara, CA) with the Acqknowledge
software package (version 3.2.4, BIOPAC). The left external jugular vein was cannulated to
allow intravenous infusion of solutions and additional anesthetic. The rats were infused
intravenously, at a rate of 1.2 ml/hr, with isotonic saline containing 6% albumin (bovine;
Calbiochem, San Diego, CA) during the surgery and thereafter with isotonic saline containing
1% albumin, 7.5% polyfructosan (Inutest, Lentz, Austria), and 1.5% para-aminohippuric acid
(PAH, Merck & Co., INC., Whitehouse Station, NJ). A suprapubic incision was made and the
bladder was exposed by blunt dissection through the abdominal wall. The bladder was
catheterized to allow timed urine collections to be made. Following the surgery the rats were
allowed to stabilize for one hour.
The experimental protocol consisted of an initial 60-min control period after which the rats
received a single intravenous injection of the AT1 receptor antagonist, losartan (Merck & Co.;
10 mg/kg, iv). After a 30-min equilibration period, a 60-min experimental period was initiated.
The effectiveness of the blockade of AT1 receptors was assessed by determining the magnitude
of the pressor response to intravenous bolus injections of 50 ng of ANG II (Sigma; 50 ml in
volume) during control conditions and at the end of the experimental period (some 90 min after
losartan administration). During both control and experimental periods, timed urine collections
and arterial blood samples (each blood sample being ~300 μl in volume) were obtained to
determine whole kidney hemodynamic function.
At the end of each experiment both kidneys were removed, decapsulated, blotted dry, and
weighed. Urine volume was determined gravimetrically. Inulin and PAH concentrations in
both urine and plasma were measured by standard spectrophotometry. Glomerular filtration
rate (GFR) and renal plasma flow (RPF) were estimated from the clearance of inulin and PAH,
respectively. Values presented for RPF were not corrected for the renal extraction of PAH.
Statistical analyses were performed using one-way and two-way ANOVA, one-way repeated
measures ANOVA, and two-way repeated measures ANOVA followed by Student-Newman-
Keuls test where appropriate. All statistical analyses were performed using SigmaPlot for
Windows (version 11, Systat Software Inc., San Jose, CA). Statistical significance was defined
as P < 0.05. All data are expressed as means ± SE.
Results
The effects of dietary administration of I3C on conscious systolic blood pressures (SBP) and
body weights of Cyp1a1-Ren2 transgenic rats are summarized in Figs. 1 and 2. Chronic
administration of 0.3% I3C for 11 days resulted in the development of severe hypertension
compared with noninduced controls (229±11 vs. 132±3 mmHg, P<0.001) (Fig. 1). The
development of hypertension was associated with a marked decrease in body weight (303±4
to 222±2 g, P<0.001) (Fig. 2). As shown in Fig. 1, SBP remained unaltered in non-induced
Fischer 344 rats and Cyp1a1-Ren2 rats induced with I3C and treated chronically with the ACE
inhibitor, lisinopril, confirming that the development of malignant hypertension is dependent
on generation of ANG II secondary to the expression of the mouse Ren2 renin gene. Body
weight increased from 348±3 to 356±4 grams (P<0.001) in the non-induced Fischer 344 rats,
and from 327±5 to 331±5 grams (P<0.05) in Cyp1a1-Ren2 rats induced with I3C and treated
chronically with the ACE inhibitor, lisinopril (Fig. 2). When I3C administration was
terminated, body weight increased to normal levels within 12 days and continued to increase
during the subsequent 9 days to a value 13% higher than the pre-I3C value (343±4 grams,
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P<0.001). However, as shown in Fig. 1, SBP remained significantly elevated (172±1 mmHg,
P<0.01) for up to 3 weeks following cessation of dietary I3C administration. Body weight
remained unaltered in non-induced Fischer 344 rats and Cyp1a1-Ren2 rats induced with I3C
and treated chronically with the ACE inhibitor, lisinopril (Fig. 2).
The effects of acute intravenous administration of losartan on mean arterial pressure (MAP)
and on the magnitude of the pressor response to bolus injections of 50 ng of ANG II are shown
in Fig. 3. Administration of losartan decreased MAP from 146±5 to 133±5 mmHg (P<0.01) in
the non-induced rats, and from 120±7 to 99±11 mmHg (P<0.01) in Cyp1a1-Ren2 rats induced
with I3C and treated chronically with lisinopril (Fig. 3A). Losartan administration elicited a
substantially greater decrease (P<0.05) in MAP in Cyp1a1-Ren2 rats induced with I3C (from
161±7 to 125±6 mmHg, P<0.01) than in the other two groups (Fig 2A). As shown in Fig. 3B,
the magnitude of the blood pressure response to intravenous bolus administration of 50 ng of
ANG II three weeks following cessation of dietary I3C (53±2 mmHg) was substantially greater
(P<0.05) than that observed in non-induced normotensive control rats (38±3 mmHg) and in
rats induced with I3C and treated chronically with lisinopril (45±1 mmHg). Acute losartan
administration markedly decreased the magnitude of the pressor response to 50 ng of ANG II
in noninduced rats (4±1 mmHg, P<0.01), in rats induced with I3C and treated chronically with
lisinopril (5±1 mmHg, p<0.01), and in Cyp1a1-Ren2 rats three weeks following cessation of
dietary I3C administration (6±1 mmHg, P<0.01) (Fig. 3B).
As shown in Fig. 4, despite the markedly elevated blood pressure, the control values for
glomerular filtration rate (GFR) and renal plasma flow (RPF) in the hypertensive rats (i.e., rats
induced with I3C alone) averaged 1.17±0.06 and 3.06±0.12 ml/min.g, respectively, values
similar to those in the non-induced rats (1.13±0.09 and 2.83±0.18, respectively) and in the rats
induced with I3C and treated chronically with lisinopril (1.00±0.11 and 2.63±0.22 ml/min.g,
respectively). Administration of losartan did not alter GFR or RPF in any of the three groups
of rats (Fig. 4).
Discussion
Cyp1a1-Ren2 transgenic rats with inducible expression of the mouse Ren2 renin gene allow
induction of various degrees of ANG II-dependent hypertension.1,13 Dietary administration of
I3C at a dose of 0.15% induces a slowly developing form of ANG II-dependent hypertension
whereas dietary administration of a higher dose (0.3%) of I3C results in the development of
ANG II-dependent malignant hypertension.13 Cessation of administration of 0.15% I3C results
in the normalization of blood pressure, indicating the reversibility of hypertension induced by
this dose of I3C.10 The present study was performed to determine if ANG II-dependent
malignant hypertension is similarly reversible following cessation of dietary administration of
0.3% I3C. Malignant hypertension is a form of severe hypertension characterized by fibrinoid
necrosis of arterioles and vascular damage in many tissues, including the kidney.1,16,20–23 This
transgenic line was generated by inserting a mouse Ren2 renin gene into the genome of the
Fischer 344 rat.1 Extrarenal Ren2 renin gene expression is induced by the administration of
the aryl hydrocarbon, I3C, resulting in the development of ANG II-dependent malignant
hypertension.1,11–17 Such induction of Ren2 renin gene expression using a benign and naturally
occurring dietary supplement leads to the development of ANG II-dependent hypertension as
a result of increased renin gene expression and plasma renin levels, which are not subject to
normal physiological feedback control mechanisms.
In the present study, induction of the Ren2 renin gene by dietary administration of 0.3% I3C
for 11 days resulted in the development of severe hypertension. As described previously11–
17, the hypertension was associated with a marked decrease in body weight, and the rats
exhibited extreme lethargy, assumption of a hunched posture, and piloerection, which are
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clinical manifestations of malignant hypertension in the rat.1,13,20–23 When administration of
0.3% I3C was terminated, SBP decreased from 229±11 to 167±4 mmHg and body weight
increased to normal levels (310±2 g, P<001) within 12 days. However, SBP remained
significantly elevated (172±1 mmHg) for up to 3 weeks following termination of dietary
administration of 0.3% I3C. Thus, in contrast to the previous observation that cessation of
dietary administration of 0.15% I3C resulted in the normalization of blood pressure, indicating
that the slowly developing hypertension induced by this dose of I3C is completely reversible,
the present findings indicate that transient induction of ANG II-dependent malignant
hypertension results in prolonged elevations of arterial blood pressure in Cyp1a1-Ren2
transgenic rats. This indicates that transient induction of malignant hypertension induces a
prolonged inability of the kidneys to maintain arterial blood pressure within the normotensive
range. The observation that acute losartan administration normalized the elevated arterial
pressures of Cyp1a1-Ren2 rats transiently induced with I3C indicates that the prolonged
elevation of arterial blood pressure observed 3 weeks following cessation of dietary I3C
administration was ANG II-dependent.
The present study demonstrates that the magnitude of the blood pressure response to
intravenous bolus administration of ANG II three weeks following cessation of dietary I3C
was substantially greater than that observed in non-induced normotensive control rats and in
rats induced with I3C and treated chronically with lisinopril. This finding indicates that the
hypertensive Cyp1a1-Ren2 rats exhibited augmented peripheral vasoconstrictor responses to
ANG II. Such enhanced peripheral vascular responsiveness to ANG II would likely enable the
elevated circulating ANG II levels13 to exert greater peripheral vasoconstrictor effects and
thereby contribute to an increased peripheral vascular resistance in hypertensive Cyp1a1-Ren2
rats. Thus, the augmented pressor responsiveness to ANG II might contribute in part to the
prolonged elevation of blood pressure that occurs following transient induction of ANG II-
dependent malignant hypertension in Cyp1a1-Ren2 transgenic rats.
The increased sensitivity to ANG II, in addition to the effects of losartan to normalize blood
pressure, suggests a fundamental role for ANG II in maintaining the hypertension following
cessation of dietary I3C administration. In this regard, we have previously demonstrated that
induction of malignant hypertension by 0.3% I3C is associated with increased plasma and
intrarenal ANG II levels.13 In addition, we have recently shown that AT1 receptor mRNA and
protein expression in kidney cortex of Cyp1a1-Ren2 rats with malignant hypertension are not
different from those in non-induced normotensive control rats.24 Thus, it is possible that the
plasma and intrarenal ANG Ievels remain inappropriately elevated three weeks following
cessation of dietary I3C administration. Such inappropriately elevated circulating and
intrarenal ANG II levels together with maintained AT1 receptor expression in the kidney cortex
would likely contribute importantly to the sustained elevation of blood pressure following
transient induction of ANG II-dependent malignant hypertension.
It should also be recognized that induction of malignant hypertension may have caused renal
injury which in turn could have contributed to the maintenance of hypertension following
cessation of dietary I3C administration. In this regard, we have demonstrated that the kidneys
of Cyp1a1-Ren2 rats with malignant hypertension exhibit myointimal hyperplasia and tubular
dilation, glomerulosclerosis, and tubulointerstitial inflammation and proliferation, particularly
in the perivascular areas.16 These findings demonstrate that the renal pathological changes that
occur in Cyp1a1-Ren2 rats with malignant hypertension consist of inflammation and cellular
proliferation in cortical vessels and tubulointerstitium.16 It is likely that such renal injury would
similarly be present in the kidneys of Cyp1a1-Ren2 rats three weeks following cessation of
dietary I3C administration. To the extent that this is the case, one would predict that such
morphological changes, together with increased ANG II generation by the inflammatory
tubulointerstitial infiltrate which has been observed in the post- ANG II salt-sensitive
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hypertension model25,26, would contribute to the sustained elevation of blood pressure
following transient induction of malignant hypertension in Cyp1a1-Ren2 transgenic rats.
In the present study, neither GFR nor RPF was altered in the hypertensive rats compared with
corresponding values observed in non-induced normotensive control rats and in rats induced
with I3C and treated chronically with lisinopril. In addition, GFR and RPF remained unaltered
in all 3 groups of rats following acute administration of losartan. These findings indicate that
ANG II-dependent reductions in renal hemodynamics were not primarily responsible for
maintaining the prolonged elevation of blood pressure that occurs following transient induction
of ANG II-dependent malignant hypertension in Cyp1a1-Ren2 transgenic rats. Rather, the
present findings that neither GFR nor RPF was altered in the hypertensive rats suggests that
enhanced tubular reabsorption of salt and water contributes importantly to the prolonged
hypertension that occurs following transient induction of ANG II-dependent malignant
hypertension in Cyp1a1-Ren2 transgenic rats. Additional studies are required to address this
issue.
In summary, the present findings demonstrate that transient induction of ANG II-dependent
malignant hypertension results in prolonged elevations of arterial blood pressure in Cyp1a1-
Ren2 transgenic rats. This indicates that transient induction of malignant hypertension induces
a prolonged inability of the kidneys to maintain arterial blood pressure within the normotensive
range. The observation that acute losartan administration normalized the elevated arterial
pressures of Cyp1a1-Ren2 rats transiently induced with I3C indicates that the prolonged
elevation of arterial blood pressure observed 3 weeks following cessation of dietary I3C
administration was ANG II-dependent. The data also demonstrate that transient induction of
ANG II-dependent malignant hypertension results in a marked augmentation of the pressor
response to ANG II in Cyp1a1-Ren2 transgenic rats. Such augmented pressor responsiveness
to ANG II might contribute in part to the prolonged elevation of blood pressure that occurs
following transient induction of ANG II-dependent malignant hypertension in Cyp1a1-Ren2
transgenic rats.
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FIG. 1.
Systolic blood pressures of transgene-negative Fischer 344 rats fed a normal diet containing
0.3% I3C (non-induced; closed squares); Cyp1a1-Ren2 rats induced with 0.3% I3C (0.3% I3C;
closed circles) for 11 days; Cyp1a1-Ren2 rats induced with 0.3% I3C and treated chronically
with the ACE inhibitor, lisinopril (50 mg/L in drinking water) (0.3% I3C+Lis; closed triangles).
* P<0.01 vs. day 0.
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Fig. 2.
Body weights of transgene-negative Fischer 344 rats fed a normal diet containing 0.3% I3C
(non-induced; closed squares); Cyp1a1-Ren2 rats induced with 0.3% I3C (0.3% I3C; closed
circles) for 11 days; Cyp1a1-Ren2 rats induced with 0.3% I3C and treated chronically with the
ACE inhibitor, lisinopril (50 mg/L in drinking water) (0.3% I3C+Lis; closed triangles). *
P<0.01 vs. day 0.
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Fig. 3.
Effects of acute administration of losartan (10 mg/kg, iv) on mean arterial blood pressures (A)
and the pressor responses to intravenous administration of 50 ng of ANG II (B) in transgene-
negative Fischer 344 rats fed a normal diet containing 0.3% I3C (non-induced; filled bars);
Cyp1a1-Ren2 rats induced with 0.3% I3C (0.3% I3C; hatched bars) for 11 days; Cyp1a1-Ren2
rats induced with 0.3% I3C and treated chronically with the ACE inhibitor, lisinopril (50 mg/
L in drinking water) (0.3% I3C+Lis; cross-hatched bars). **P<0.01 vs. corresponding control
value; † P<0.05 vs. non-induced.
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Fig. 4.
Effects of acute administration of losartan (10 mg/kg, iv) on glomerular filtration rate (A) and
renal plasma flow (B) in transgene-negative Fischer 344 rats fed a normal diet containing 0.3%
I3C (non-induced; filled bars); Cyp1a1-Ren2 rats induced with 0.3% I3C (0.3% I3C; hatched
bars) for 11 days; Cyp1a1-Ren2 rats induced with 0.3% I3C and treated chronically with the
ACE inhibitor, lisinopril (50 mg/L in drinking water) (0.3% I3C+Lis; cross-hatched bars).
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